Pretomanid Resistance Is a Question of When, Not If, and Diagnostics Have to Be Ready Before It Arrives Read more EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance Diagnostics Read more Beyond Speed: Why Expanded Drug Resistance Testing Is the Next Frontier in Tuberculosis Diagnostics Read more Bedaquiline Resistance: Why a Tiered Diagnostic Strategy Is the Way Forward Read more EMPE Diagnostics Partners with Interprise to Expand Access to TB Drug Resistance Diagnostics Across Brazil Read more Lessons from Ukraine: Bringing Next-Generation Molecular TB Diagnostics to the Frontlines Read more Tuberculosis Kills More People Than Any Other Infection. Here’s How We’re Building the Company to Change That. Read more Contract Manufacturing: Blending Agility with Speed to Market Read more Uganda’s TB Progress Highlights a Critical Lesson: Diagnostics Need Strong Health Systems Read more The Cost of Silence: Why Early Detection is the Only Way to Stop Ebola Read more Bridging the Global TB Diagnostic Gap: The Clinical Rigor Behind EMPE TBDx Read more Advancing Healthcare Diagnostics: Why Rwanda is the New Frontier for TB Innovation Read more 1 2
